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Enterobacter cloacae is a Gram-negative, opportunistic bacterial pathogen that is commonly 
acquired by patients in hospitals. The Type VI Secretion System (T6SS) is a harpoon-like 
apparatus that injects toxins into the cell envelop of neighboring bacteria to defend or compete 
for resources. It’s commonly found in a range of bacteria including Vibrio cholerae, 
Pseudomonas aeruginosa, and Escherichia coli. Previous research in this lab has shown that E. 
cloacae kills in a contact dependent manner and bioinformatic analysis found three vask genes, 
which encode for a protein in the Type VI apparatus. We created three single mutant strains 
(Δvask1, Δvask2, Δvask3) as well a double mutant (Δvask1Δvask3). These strains were tested in 
competition assays with target WT E. coli, with the survival of the target being indicative of E. 
cloacae killing ability. We show here that Δvask2 had no change in killing ability, Δvask1 and 
Δvask3 had some reduction in killing ability, and Δvask1Δvask3 had a complete reduction in 





Enterobacter cloacae is a Gram-negative, opportunistic bacterial pathogen that is 
commonly found in hospitals where it colonizes surgical equipment and forms biofilms on 
devices.1 While up to 80% of the population can have E. cloacae living benignly in the 
gastrointestinal (GI) tract, it becomes dangerous in immunocompromised individuals.2 As E. 
cloacae continues to rise in prevalence at hospitals around the country, research has been 
increasingly focused on potential virulence factors.3 E. cloacae has the ability to adhere to other 
cells, produce an iron chelating agent called aerobactin, and encodes several secretion systems.2,4 
The ability to adhere to cells is a necessary property in order to form biofilms, which are attached 
polymicrobial communities of cells that communicate and cooperate with each other. 
There are seven types secretion systems (T1SS-T7SS) found within the bacterial world, 
each unique in its structure and function.10  Specifically, E. cloacae contains multiple Type VI 
Secretion Systems (T6SS) which are encoded on separate loci. T6SS is a harpoon-like apparatus 
commonly found in Gram-negative bacteria that injects toxins into the cell envelope of 
neighboring bacteria to defend or compete for resources.5 E. cloacae is a complex pathogen with 
many internal mechanisms to uncover. Our research focuses specifically on the T6SS in E. 
cloacae and ultimately how it contributes to competition and pathogenicity. 
While T6SS has been widely studied in a variety of pathogens such as Vibrio cholerae 
and Pseudomonas aeruginosa, little research has been conducted on the T6SSs in E. cloacae. To 
date, only one paper has been published that describes the role of each T6SS in the clinical E. 
cloacae  reference strain ATCC13047. Our study investigates the E. cloacae environmental 
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isolate ZOR0014 taken from a zebrafish by the Parthasarathy lab at the University of Oregon, 
which has not been studied before in this context. 
Previous research in this lab done by M.S. student Vishnu Raghuram established E. 
cloacae ZOR0014’s virulence against V. cholerae and other pathogens (Fig. 1), including E. coli 
(not shown in Fig. 1). He was also able to show that when E. cloacae ZOR0014 was separated 
from its target strain with filters, it was unable to kill that target (Fig. 1). This established contact 
dependent killing which is indicative of a Type VI secretion system.  
 
Next, M.S. students Mansi Gupta and Jessica Mulligan set out to establish through 
bioinformatic analysis whether E. cloacae ZOR0014 contained a T6SS loci, how many and 
where they were located. They were able to find three vask genes, which encode for a protein in 
the T6SS. Two of these are confirmed to be located in large clusters with other T6SS genes while 
Figure 1. Preliminary research established that E. cloacae was able to kill a variety of 
other bacterial species. E. cloacae ZOR0014 was co-cultured in competition assays with V. 
cholerae, aeromonas, plesiomonas, and acinetobacter in a 1:10 ratio (E. cloacae ZOR0014: 
target strain). A negative control in which the target strains were cultured without E. cloacae 
is on the right for comparison. (Figure from Vishnu Raghuram) 
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the third is in a smaller cluster. It is still unknown if the third vask is part of a T6SS loci or 
independent.  
Our first goal is to confirm the presence of these T6SSs and discern to what degree each 
contributes to interbacterial competition between E. cloacae ZOR0014 and the model bacterium 
E. coli in vitro. Following our study, these strains will be used by our collaborators in the 
Parthasarathy lab for in vivo experiments in the zebrafish host to study the contribution of T6SS 
activity in a relevant animal model. Zebrafish are unique model organisms due to their ability to 
stay sterile for the first 14 days and their transparency allows for direct visualization of internal 
mechanisms as a result of colonization by fluorescently-labeled microbes including E. cloacae.6 
Understanding precisely how T6SS affects E. cloacae’s ability to interact, compete, and colonize 
in a live host is crucial to making progress in combating this pathogen. 
Literature Review 
E. cloacae is a Gram-negative, opportunistic bacterial pathogen. It is commonly found as 
a benign commensal gut bacterium in up to 80% of human gastrointestinal (GI) tracts but 
becomes problematic in immunocompromised patients.2 E. cloacae is often found in biofilms on 
surgical equipment or intravenous devices, which can cause infections.1 This bacterium causes 
many hospital-acquired infections such as urinary tract infections, osteomyelitis, cholecystitis, 
meningitis, bacteremia, and lower respiratory tract infections.7 This pathogen is increasingly 
important to study as its prevalence in hospitals continues to rise, currently accounting for 7% of 
all nosocomial infections within the United States.3 Concerningly, E. cloacae is also inherently 
resistant to several antibiotics, including ampicillin, amoxicillin–clavulanic acid, and 
cephalothin.1 In fact, E. cloacae is the second most common carbapenem-resistant 
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Enterobacteriaceae (CRE) in the United States.8 However, there are multiple strains of E. 
cloacae isolated from both environmental and clinical sources. Research conducted on one strain 
is not always applicable to others. For example, there are certain strains of E. cloacae which are 
not inherently resistant to ampicillin, which underscores the value of studying more than a single 
reference strain of a bacterial species. 
Due to E. cloacae’s increasing prevalence, understanding its virulence properties has 
become a point of interest for researchers over the past couple decades. Initial studies found that 
E. cloacae has the ability to produce aerobactin, an iron chelating agent, and adhere to other 
cells. Aerobactin is a known virulence factor in E. coli due to its ability to sequester iron.2  Iron 
is an essential nutrient for hosts and when deprived of it, the host's condition deteriorates. Cell 
adherence is a common measure of virulence because this allows cells to form biofilms which 
can cause infections.  More recent studies have shown that E. cloacae’s pathogenicity is 
dependent on a variety of other things as well, such as outer membrane proteins, efflux pumps 
and secretion systems.4, 9       
Secretion systems are very common in bacterial pathogens. To date, there have been 
seven systems discovered (T1SS-T7SS). Each system is unique and provides different functions, 
but they all contribute to bacterial growth and virulence in some way.10 These secretion systems 
are encoded on gene clusters in bacterial chromosomes. Genomic analysis of various E. cloacae 
strains has indicated that they contain multiple Type VI Secretion Systems (T6SS).11 T6SS is a 
harpoon-like apparatus commonly found in Gram-negative bacteria that injects toxins into the 
cell envelope of neighboring bacteria to defend or compete for resources. T6SS was first 
discovered by Mougous, et al. in Pseudomonas aeruginosa. P. aeruginosa is a commonly found 
bacterium in the lungs of cystic fibrosis (CF) patients. The researchers found components of the 
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T6SS apparatus in pulmonary secretions of these patients, indicating that T6SS might contribute 
to P. aeruginosa pathogenicity and ability to colonize CF lungs.5 T6SS has since been shown to 
be present in up to 25% of all Gram-negative bacteria, including Escherichia coli, Vibrio 
cholerae, and Enterobacter cloacae. 11,12,13,14 
The T6SS apparatus consists of at least 13 subunits that are encoded by anywhere from 
12-20 genes. T6SS is composed of three sections: the proteins forming the membrane, the tail 
complex and the baseplate complex.12 The T6SS has an inner tube, or “harpoon”, topped with a 
conical protein containing toxins, surrounded by an outer membrane. The harpoon is fired into 
neighboring cells, piercing their membranes and injecting the toxins, causing lysis and death of 
the cell.  Most species have one or two T6SS clusters each encoding for an apparatus, but certain 
species can have up to six.15    
Besides its initial discovery in P. aeruginosa, T6SS has been shown to contribute to 
virulence in other bacteria as well. When introduced into live zebrafish, V. cholerae was shown 
to induce gut contractions, or peristalsis, which expelled resident bacteria into the water supply 
in order to infect more hosts. Researchers disrupted crucial T6SS genes in V. cholerae and found 
that the bacteria had harder time colonizing the host zebrafish and expelling itself.13 Studies 
conducted in vivo have shown that mutants lacking critical T6SS genes have significantly lower 
ability to kill neighboring bacteria, such as E. coli. Similar in vivo results have been observed for 
studies of the T6SS various species of enterobacteria.16    
Compared to other bacteria, E. cloacae’s Type VI secretion systems have been 
understudied. Recently, a paper published by Soria-Bustos, et al. described the role both T6SSs 
play within E. cloacae.11 They discovered that one of the T6SS contributes to interbacterial 
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competition and biofilm formation in vitro, the second contributes to cell adherence in vitro and 
both are necessary for in vivo colonization using mouse models.11 However, much is still 
unknown about T6SS in E. cloacae and the role it plays in interbacterial competition with a wide 
variety of bacteria. This is also the only paper covering T6SSs role in E. cloacae specifically. 
Results 
After finding the locations of the vask genes, myself and Jessica Mulligan worked on 
disrupting them under the guidance of graduate student Siu Lung Ng. To access the effectiveness 
of the multiple T6SS’s in E. cloacae, we disrupted (vask1 and vask3) or deleted (vask2) the vask 
genes, which encode for a protein in the T6SS. 
We established an appropriate ratio for competing E. cloacae against E. coli. Various 
ratios of killer to target were tested, including 1:12, 1:10, 1:8, 1:4, and 1:2 (Fig. 2A) before 
deciding the 1:2 ratio was ideal for visualizing the differences between mutants (Fig. 2B). This 
allowed for up to 3 log differences to be clearly seen between the E. cloacae strains.  
The phenotypes were assessed through competition assays, first with spot plating and 
then quantified with colony forming units (CFUs). Each of the single mutant strains (Δvask1, 
Δvask2, Δvask3 – Fig. 3, blue bars) and the double mutant (Δvask1Δvask3 – Fig. 3B, green bar) 
were co-cultured with WT E. coli. For reference, WT E. cloacae ZOR0014 as a positive control 
(Fig. 3B, orange bar) and WT E. cloacae ZOR0014 + filter as a negative control (Fig. 3B, brown 
bar) were also co-cultured with E. coli. The filter blocks any contact between the two strains, 
allowing uninhibited E. coli growth.  
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E. cloacae’s killing ability was measured through E. coli survival – the higher E. coli 
survival, the worse E. cloacae’s relative ability to kill was. The Δvask1 mutation showed a 
partial reduction in killing by about one log (Fig. 3B). E. coli survival was between that of the 
WT E. cloacae ZOR0014 but not completely reduced to the level of the negative control. The 
Δvask2 mutant showed no reduction in killing ability. It displayed the same level of E. coli 
survival as the original wildtype E. cloacae ZOR0014 (Fig. 3B). The Δvask3 mutant showed 
reduced killing ability by half a log when competed against E. coli (Fig. 3B). The double 
Δvask1Δvask3 mutant showed a complete reduction in killing ability, with E. coli survival 
increasing by about 3 logs (Fig. 3B). The E. coli survival against the double mutant was nearly 
exactly the same as the double filter negative control. 
While these were the initial results, statistical analysis of CFU counts showed slightly 
different results. While the reduction in killing for the Δvask1 mutant is statistically significant 
from the wildtype, the Δvask2 mutant and Δvask3 mutant was not (Fig. 3B). The difference in E. 
coli survival between the WT E. cloacae ZOR0014 and the Δvask1Δvask3 mutant was significant 
(Fig. 3B). Additionally, there was no significant difference between the negative control (WT + 





Figure 2. 1:2 ratio of E. cloacae strains to WT E. coli produces the best results for 
visualizing the differences between strains. (A) WT E. cloacae ZOR0014, WT E. cloacae 
ZOR0014 + filter, and a sample of the mutants (Δvask3 and Δvask1Δvask3) were co-cultured in a 
competition assay with WT E. coli in four different ratios: 1:4, 1:8, 1:10, and 1:12 (E. cloacae: E. 
coli). (B) Additionally, a 1:2 ratio was tested with all three single mutants and the double mutant 
E. cloacae strains. Duplicates of each combination are shown here.  
A 
B 




Figure 3. E. cloacae has two functioning Type VI Secretion Systems that contribute to 
contact dependent killing in vitro. (A) Preliminary results from a competition assay (B) 
This was quantified by measuring CFUs. The WT E. cloacae ZOR0014 strain (orange bar), 
WT E. cloacae ZOR0014 + filter (brown bar), three single vask mutants (Δvask1, Δvask2, 
Δvask3 - blue bars) and the double mutant  (Δvask1Δvask3 – green bar) were co-cultured 
with WT E. coli. Data shown is the mean survival of triplicates +/- standard deviation. A 
one-way ANOVA test with Tukey-Kramer post hoc test was used to determine 







Bioinformatic analysis of the E. cloacae genome has indicated that there are three vask 
loci, two large and one small cluster. Previously, it was unknown whether these loci were active 
and contributed to T6SS mediated killing. Our work so far has disrupted/deleted all three of the 
vask loci, named vask1, vask2 and vask3, which correlate to T6SS1, T6SS2, and T6SS3, 
respectively. E. cloacae Δvask1 was competed against wildtype E. coli to assess changes in 
killing ability. It was found that E. cloacae Δvask1 displayed partial decreased killing ability 
towards E. coli, indicating that T6SS1 was functional and active in T6SS mediated killing.  
However, since E. coli survival was still lower than the negative control, T6SS1 could not have 
been entirely responsible for all of E. cloacae T6SS mediated killing. The same experiment was 
performed for E. cloacae Δvask2 and it was found to have no effect on E. coli survival. This 
indicated that either T6SS2 was not involved in E. cloacae ZOR0014 T6SS mediated killing or 
that this vask2 gene was not part of a Type VI cluster. Since vask2 was found in the smaller 
cluster and it is unknown whether other necessary genes for T6SS are included in this cluster, it 
seems feasible that vask2 might be independent of a T6SS.  
The third mutant, Δvask3, showed a reduced capacity for killing but not to the level 
Δvask1. While Δvask1 experienced one log of increased E. coli survival, Δvask3 only had a half 
log increase. Again, this indicated that vask3 is functional and active and T6SS3 contributes to 
T6SS mediated killing. However, when statistical analysis was applied to the differences 
between all three single mutants and the WT E. cloacae ZOR0014, it was found that there was 
not a statistically significant difference for the Δvask2 and Δvask3 mutants but there was for 
Δvask1 (Fig. 4). Disrupting T6SS3 on its own does not significantly impair E. cloacae’s ability 
to kill its predator, nor does disrupting T6SS2. We wondered what effect disrupting both the 
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T6SS1 and T6SS3 would have. Based on our preliminary results,  it seemed likely that both 
T6SS1 and T6SS3 together were responsible for the E. cloacae’s ability to kill.   
The next step was to test the double mutant (Δvask1Δvask3) to observe the effect that 
knocking out both T6SS’s will have on E. cloacae’s killing ability. The double mutant showed a 
complete reduction in contact dependent killing ability, with about three logs increase in E. coli 
survival, which compared to the wildtype survival was statistically significant. This likely 
indicates the T6SS1 and T6SS3 are both necessary for contact dependent killing. Additionally, 
there was no statistically significant difference between the negative control (WT + filter) and 
the double mutant (Fig. 3). Moving forward, the double mutant can be used as an effective 
replacement for the double filter method to obtain a negative control.  
Several bacteria, like Pseudomonas aeruginosa PA01, encode multiple T6SSs (H1-T6SS, 
H2-T6SS, and H3-T6SS) that play distinct roles in different conditions17. For example, in P. 
aeruginosa the H1-T6SS display anti-prokaryotic activity. By contrast, the H2-T6SS and H3-
T6SS show both anti-prokaryotic and anti-eukaryotic activity that appear to contribute to 
epithelial cell invasion in vivo. As a result, moving forward, a triple mutant disrupting all three 
vask genes needs to be made. Initial results indicated that Δvask2 did not impair E. cloacae 
killing ability at all in vitro. However, considering that both the single Δvask1 and Δvask3 had 
small increases in E. coli survival, but when both genes were disrupted together exhibited a 
much significantly larger increase in survival, it’s necessary to make a triple mutant to rule out 
the possibly of Δvask2 having an effect in conjunction with Δvask1 and Δvask3. Additionally, 
these strains will be sent back to our collaborators in the Parthasarathy lab to be tested in vivo. 
While the Δvask2 mutant may show no difference in vitro, it could potentially behave very 




Our research will help expand on the role of T6SS in E. cloacae, particularly as it 
pertains to virulence. While studies done on other E. cloacae strains, such as the standard clinical 
strain ATCC13047, have elucidated a lot of information, this is not always applicable to other 
strains. Specifically, the strain used in our research (ZOR0014) is a unique environmental isolate 
taken from the intestines of a zebrafish and to date,  no studies have been published with this 
particular strain. This strain is valuable because of its ability to be studied in zebrafish models. 
Zebrafish models are uniquely valuable model organisms due to their ability to stay sterile in the 
first 14 days and their transparency, allowing for full visualization of internal mechanisms. This 
technique allows for a high degree of control, excellent visualization and a more precise 
understanding of how E. cloacae interacts in vivo in regard to T6SS. 
Our research to date has shown that single Δvask1 and Δvask3 E. cloacae mutants show a 
partial reduction in killing ability in comparison to the WT E. cloacae. However, the differences 
were only significant for Δvask1. When both of these genes are disrupted together in a double 
Δvask1Δvask3 mutant, there is a significant reduction in killing ability. Initial results indicated 
that the Δvask2 mutant doesn’t play a role in E. cloacae’s T6SS mediated killing in vitro. 
However,  Δvask2 may behave very differently in vivo where it is exposed to other factors, such 
as anti-eukaryotic effectors in a fish host. Additionally, developing and testing a triple mutant 
(Δvask1Δvask2Δvask3) along with the rest of these strains in a live zebrafish model will provide 




The T6SS plays a big role in the ability to compete and defend for resources in bacteria 
like E. cloacae. E. cloacae is a relatively understudied bacterium despite its many problematic 
characteristics, especially as it pertains to human health. Investigating and understanding a major 
system that E. cloacae uses to potentially harm its host is invaluable. The work done in this 
project is foundational and can easily be built upon in the future.  
Methods and Techniques 
Bacterial Strains and Growth Conditions 
Enterobacter strain ZOR0014 used in this study was an environmental isolate obtained from 
zebrafish commensals sent by collaborators at the University of Oregon.18 E. coli MG1655 CmR 
was used as prey in the killing assays. All strains were grown with liquid lysogenic broth (LB) 
medium or on LB agar at 37 °C overnight with appropriate antibiotics.  
The LB medium was made by adding 10 g tryptone, 5 g sodium chloride, and 10 g yeast per liter 
(in the case of plates, 15 g of agar was added to the mixture) and the mixture was sterilized.  
Kanamycin and ampicillin were added at 1 µg/mL, gentamycin at 0.33 µg/mL and 
diaminopimelic acid (DAP) at 2 µg/mL.  
Disrupting ZOR0014 vask1 and vask2   
A vask2 of ZOR0014 was constructed prior with assistance from Siu Lung Ng and not 
described here. A dap auxotrophic E. coli lambda-pir donor strain was used to deliver suicide 
vectors into ZOR0014 by conjugation. Growth of the dap auxotroph requires the addition of 
DAP (diaminopimelic acid) to agar plates, and its omission prevents donor growth. The pKAS-
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vask1 vector encodes kanamycin resistance, the pKAS-vask3 vector encodes gentamycin 
resistance. Each suicide vector has an R6K origin of replication that restricts its replication to the 
E. coli donor strain carrying the Pir protein on its chromosome. Each suicide vector was 
constructed by Siu Lung Ng by PCR amplification of a 1000 bp DNA sequence of a vask gene 
that was cloned into the vector backbone by Gibson assembly, as described in Crisan, 2019. 
Once delivered into ZOR0014, neither vector can replicate. However, one can select for a rare 
recombination event of the vector into the chromosome by plating on agar containing antibiotic 
(kanamycin for pKAS-vask1, or gentamycin for pKAS-vask3).  
Liquid overnight cultures of each E. coli donor were mixed with a liquid culture of the 
ZOR0014 isolate in a 1:8 ratio. 50 µl of each mixture was plated in a small patch on LB agar 
supplemented with DAP to ensure donor growth, and incubated overnight at 37°C. The 
following day, cells were scraped from the patch and placed into 1 mL of liquid LB. Ten-fold 
serial dilutions were performed. 50 µl of each dilution was plated on agar lacking DAP but 
supplemented with kanamycin (for vask1) or gentamycin (for vask3). Overnight incubation at 
37°C selected for ZOR0014 recipients with integrated vectors and eliminated the E. coli dap 
auxotrophic donor. Multiple surviving colonies from each of the plates were selected and re-
streaked on agar plates with antibiotic for the next two days. Frozen stocks of the ZOR0014 
candidate mutants were also made (50% overnight grown in 5 mL liquid LB with antibiotic and 
50% glycerol).  
Confirming vasK disruptions 
Genomic DNA purification was done on two candidate mutants (prepared using the methods 
described above) along with ZOR0014 as a control. The purification was conducted using QIA 
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Spin MiniPrep Kit in accordance with those specific instructions. After DNA purification, PCR 
was performed on the DNA using 5xTaq PCR protocol. An annealing temperature of 55°C and 
an elongation time of 40 minutes was used. The PCR product was run on a 1% agarose gel at 100 
V for 60 minutes. The primers (GT3202/GT3203) used for the PCR annealed in positions that 
produced a PCR product of ~1 kb from template DNA derived from ZOR0014. By contrast, each 
vasK disruption was confirmed by a PCR product that was 10 kb due to integration of the suicide 
vector into the chromosome. 
Killing Assay Conditions 
Both E. coli and ZOR0014 were grown overnight in liquid LB medium with shaking at 37°C. 
The strains were normalized to an OD600 of 1.0. Predator ZOR0014 (environmental and 
genetically modified, KanR) and prey E. coli were mixed at a ratio of 1:8 and 50 µl of each 
suspension was then spotted onto LB agar plates. The plates were incubated for 3 h at 37°C. The 
agar spot patches were removed with a sterilized tool and placed into Falcon tubes. The cells 
were removed from the agar by vortexing for 30 seconds in 5 mL of LB medium. The cells were 
serially diluted ten-fold and spot plated on LB agar. The plates were grown overnight at 37°C 








Figure 4 – Killing Assay Protocol to (A) allow and (B) prevent contact between 
competitors. (A) E. coli and ZOR0014 were mixed together in a 1:8 ratio after being 
normalized to OD600 of 1.0. 50 µl of the mixture was plated on LB agar and incubated for 3 
hrs at 37°C. The agar patches were removed using a flame sterilized spatula and placed into 5 
mL of liquid LB in a falcon tube and vortexed for 30 seconds. Ten-fold dilutions of each 
sample was made. If spot plating, 5 µl of every dilution for each sample was plated on agar + 
CM. If counting CFUs, for each sample 100 ul µl of one dilution (varies per sample) was 
spread on agar + CM using beads. (B) E. coli and ZOR0014 were normalize to OD600 of 1.0. 
A filter was placed directly onto an agar plate. 43.75 µl of ZOR0014 was placed in a 2x2 grid 
on top of the filter. After the patch was dry, another filter was laid directly on top of the first 
one. 6.25 µl of E. coli was placed in the same 2x2 patch on top of the second filter. The plates 
were incubated for 3 hrs at 37°C. The top filter was removed using a flame sterilized forceps 
and placed in a Falcon tube with 5 mL of LB and vortexed for 30 seconds. The rest of the 
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